Structure Therapeutics Inc. (GPCR)
NASDAQ: GPCR · Real-Time Price · USD
28.98
-2.29 (-7.32%)
Oct 1, 2026, 4:00 PM EDT - Market closed
Structure Therapeutics Stock Forecast
Stock Price Forecast
According to 16 analysts polled by S&P Global, Structure Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $105.78. The average 1-year stock price forecast is 265.01% higher than the current stock price, while the lowest is $70 (+141.55%) and the highest is $145 (+400.35%).
Price Target: $105.78 (+265.01%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Structure Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 12 | 12 | 12 | 11 | 11 | 11 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 17 | 17 | 17 | 16 | 16 | 16 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $111 | Buy | Maintains | $111 | +283.02% | Sep 9, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $70 | Buy | Reiterates | $70 | +141.55% | Sep 9, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $104 | Buy | Maintains | $104 | +258.87% | Sep 8, 2026 |
| Jefferies | Jefferies | Buy Maintains $125 | Buy | Maintains | $125 | +331.33% | Sep 8, 2026 |
| William Blair | William Blair | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Sep 8, 2026 |
Financial Forecast
Revenue This Year
41.67M
Revenue Next Year
45.45K
from 41.67M
Decreased by -99.89%
EPS This Year
-1.61
from -1.42
EPS Next Year
-2.11
from -1.61
EPS and Forward PE are based on non-GAAP adjusted numbers.